This longitudinal studyassessedfatigue and treatment status in patients with Atypical hemolytic uremic syndrome (aHUS) from the Global aHUS Registry.
The results confirm the detrimental effects of aHUS on patients’ daily lives, especially in terms of fatigue,butdemonstratessignificant improvement in symptoms following treatment with eculizumab.
Kidney International® A Toolkit for ISN’s Registry Initiative, SharE-RR This paper, led by... read more
Kidney International® Executive Summary of the KDIGO 2024 Clinical Practice Guideline for... read more
Kidney International® Executive Summary of the KDIGO 2024 Clinical Practice Guideline for... read more
Kidney International® Kidney Biopsies Among Persons Living in Hotspots of Ckdu: A... read more
Submit your manuscript here by July 31, 2024 Kidney International Reports® will... read more
Kidney International® Providing Environmentally Sustainable Nephrology Care: Focus in Low- and Middle-income... read more
Kidney International® Living Kidney Donors’ Healthcare Needs, Experiences and Perspectives Across Their... read more
Kidney International® Conservative Kidney Management and Kidney Supportive Care: Core Components of... read more
Kidney International® Executive Summary of the KDIGO 2024 Clinical Practice Guideline for... read more
Best Basic/Translational and Clinical Science publications in Kidney International® - KI-ISN Early-Career... read more
